Following participation in this program, participants will be able to:

• Update knowledge on the new Canadian guidelines for dyslipidemia
• Identify and understand the changes compared to previous recommendations
• Determine which high-risk patients could benefit from an additional reduction in LDL-C levels
• Integrate therapeutic options into practice

Faculty

John L. Sievenpiper: MD, PhD, FRCPC
Member of the 2021 CCS dyslipidemia guideline 
St. Michael’s Hospital